Check out your Company Bowl for anonymous work chats.
"If you bring powerful technology to a problem that is well understood, then you can really make a difference." - Marc Lajoie, CEO at Outpace Bio Welcome to Biorasi's Few & Far Between podcast. Thank you for joining us for our final episode of 2024. Host Chris O'Brien welcomes guest, Marc Lajoie, to discuss how de novo proteins can be used to reprogram immune cells. Tune in today! Find this new episode on your favorite streaming platform or visit >> https://lnkd.in/g2KE2SGA
At Biorasi, our dedicated team of experts is with you right from the start. #OneTeam members Daniel Heinbaugh and Stephen Caron explain the importance of collaboration and commitment in our latest video.
Congratulations to our CEO Chris O'Brien on teaching his first Harvard Business School class. The entire Biorasi #OneTeam is very proud!
How does diversity create more inclusive clinical trials? Learn the importance of embracing diversity in our latest Resouce Library article.
Is your clinical trial becoming a MONSTER? Learn the 4 signs of an out-of-control trial in Biorasi's 2024 Halloween video.
